Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nanoparticles based on gadolinium coordination polymers as highly sensitive T1 MRI contrast agents

Nanoparticles based on gadolinium coordination polymers as highly sensitive T1 MRI contrast agents

US Patent 8940275 · Granted Jan 27, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Photodynamic therapy composition2025
PSMA targeted conjugate compounds and uses thereof2024
PSMA ligand targeted compounds and uses thereof2024
Composition and methods for imaging cells2024
PSMA targeted compounds and uses thereof2024
Photodynamic therapy composition2024
Targeted non-invasive imaging probes of EGFR expressing cells2023
PSMA targeted conjugate compounds and uses thereof2021
Targeted nanoparticle conjugates2021
Photodynamic therapy composition2020
Deuterated metabolic water precursor for detecting and treating diseased tissue2020
Composition and methods for imaging cells2019